Cimpress (CMPR)
(Delayed Data from NSDQ)
$79.66 USD
-0.69 (-0.86%)
Updated Nov 8, 2024 04:00 PM ET
After-Market: $79.73 +0.07 (0.09%) 7:58 PM ET
4-Sell of 5 4
A Value A Growth C Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$79.66 USD
-0.69 (-0.86%)
Updated Nov 8, 2024 04:00 PM ET
After-Market: $79.73 +0.07 (0.09%) 7:58 PM ET
4-Sell of 5 4
A Value A Growth C Momentum A VGM
Zacks News
Eurozone Beats United States Again: 5 Hot Stock Picks
by Zacks Equity Research
5 Europe-based stocks to buy as the region scores decade-high growth rate in 2017.
Parker-Hannifin (PH) Introduces Low-Lead Solenoid Valves
by Zacks Equity Research
Parker-Hannifin (PH) launches a Low-Lead Brass body series of solenoid valves for beverage dispensing industry.
Zacks.com highlights: HCA Healthcare, Cimpress N.V. and Virtu Financial
by Zacks Equity Research
Zacks.com highlights: HCA Healthcare, Cimpress N.V. and Virtu Financial
3 Low-Beta Stocks to Ease Jitters From Market Volatility
by Zacks Equity Research
Our intense research has developed a strategy that allows investors to spend money on securities with lower risk and fetch attractive returns.
5 Must Buy Stocks After Volatility Explodes
by David Bartosiak
These five Zacks Rank #1 (Strong Buy) stocks are on sale after volatility exploded in the market.
Cimpress (CMPR) Jumps: Stock Rises 6.2%
by Zacks Equity Research
The shares of Cimpress (CMPR) rose 6.2% on Friday.
Cimpress (CMPR) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Cimpress (CMPR) Q2 earnings decline due to significant rise in operating expenses despite top-line growth.
Industrial Stocks' Earnings on Jan 31: JCI, IR, AVY, CMPR
by Supriyo Bose
The Industrial Products sector appears to be quite strong. Let's take a sneak peek at four major Industrial stocks scheduled to report earnings tomorrow to see how things are shaping up for the upcoming results.
Cimpress Rides on Portfolio Restructuring, Risks Persist
by Zacks Equity Research
Cimpress' (CMPR) business is scalable and its web presence and online tools for customer use are well established, although foreign currency woes remain potential headwinds.
Bemis Rides on Restructuring Plan, Hurricane Effect a Woe
by Zacks Equity Research
Bemis' (BMS) restructuring plan will help align its manufacturing and administrative cost structures with current business environment. However, its results will be hurt by rising raw material prices.
New Strong Sell Stocks for October 10th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
Cimpress (CMPR) Maintains Core Business Focus, Risks Remain
by Supriyo Bose
Cimpress N.V.'s (CMPR) business is scalable and its web presence and online tools for customer use are well established although foreign currency woes remain potential headwinds.
Cimpress (CMPR) Shows Long-Term Promise with Holistic Growth
by Zacks Equity Research
Cimpress N.V.'s (CMPR) business is scalable and its web presence and online tools for customer use are well established.
Cimpress (CMPR) Q4 Loss Wider than Expected, Revenues Beat
by Zacks Equity Research
Cimpress N.V. (CMPR) reports wider-than-expected loss due to the year-over-year impact of non-operational and non-cash currency.
Pentair (PNR) Posts In-Line Q2 Earnings, Updates 2017 View
by Zacks Equity Research
Pentair (PNR) posted second-quarter 2017 adjusted earnings of $1.00 per share, which climbed 13.6% year over year and came ahead of the guided range.
Avery Dennison (AVY) Q2 Earnings & Sales Beat Estimates
by Zacks Equity Research
Avery Dennison (AVY) posted adjusted earnings of $1.31 per share for Q2, beating the Consensus mark. The company will ride high on strong operating performance and execution of strategies.
Dover (DOV) Q2 Earnings Beat, Up Y/Y, '17 Guidance Raised
by Zacks Equity Research
Dover's (DOV) second-quarter 2017 revenue growth and margin expansion surpassed forecast. The company raised revenue and EPS guidance for full-year 2017, driven by solid second-quarter performance.
Grainger (GWW) Beats on Q2 Earnings, Maintains FY17 View
by Zacks Equity Research
Grainger (GWW) beat second-quarter 2017 earnings, but missed on revenues. The company reaffirmed its 2017 guidance.
Here's Why You Should Sell Cimpress (CMPR) Stock Right Now
by Zacks Equity Research
Cimpress currently carries a Zacks Rank #5 (Strong Sell). Let's have a look at the factors which are affecting stock.
Cimpress (CMPR) Reports Wider-than-Expected Loss in Q3
by Zacks Equity Research
Business services provider Cimpress N.V. (CMPR) reported lackluster third-quarter fiscal 2017 results
Why Is Cimpress (CMPR) Down 3.6% Since the Last Earnings Report?
by Zacks Equity Research
Cimpress (CMPR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Cimpress (CMPR) Lags Q2 Earnings & Revenues, Stock Falls
by Zacks Equity Research
Cimpress N.V. (CMPR) reported lackluster second-quarter fiscal 2017 results missing both GAAP earnings and revenue estimates.
Cimpress Inks Deal to Buy National Pen to Expand Portfolio
by Zacks Equity Research
Cimpress N.V. (CMPR) inked a definitive agreement to acquire National Pen Co. LLC, for approximately $218 million, subjected to customary adjustments.
Using the Short Ratio to Forecast Turning Points
by Kevin Matras
Kevin Matras looks at the 'short ratio' as a market sentiment indicator and shows how to use it for finding winning stocks. Highlighted stocks include CRI, GTLS, RMD, VPRT and WWAV.